JERROD CONKLING: Open Payments
NPI 1114950706 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,301 in 139 payments from 30 companies in 2025. Trend: 2023 $872 · 2024 $1,819 · 2025 $2,301
Food & beverage: $2,301
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 38 | $250 |
| Amgen Inc. | 15 | $210 |
| Abbott Laboratories | 5 | $197 |
| Xeris Pharmaceuticals, Inc. | 12 | $180 |
| RECORDATI_RARE_DISEASES_INC. | 7 | $164 |
| Medtronic, Inc. | 6 | $151 |
| Dexcom, Inc. | 5 | $120 |
| Lilly USA, LLC | 7 | $116 |
| Corcept Therapeutics | 6 | $108 |
| Aimmune Therapeutics, Inc. | 3 | $81 |
Products named: Omnipod, FREESTYLE LIBRE 3, ISTURISA, Dexcom G6 Transmitter, MOUNJARO, Korlym, INTELLIS ADAPTIVESTIM, RECORLEV.
Industry payments across KS — which companies pay providers there.
